Opioids & Driving: Know the RisksFeb 25, 2019 2:03:00 PM by Jody Lutz
At AffirmHealth we have focused extensively on covering our nation's drug crisis -- it’s impact on patients, physicians and their practices. We have studied the changing laws and dynamics around how practitioners prescribe and the resulting effect on patients. Today we are taking the discussion to the open road, a topic that has been covered by many a country and western ballad and is part of the American way of life.Read More
New York's Drug Take Back ActJan 23, 2019 3:19:42 PM by Jody Lutz
A report released in November of 2018, from the Centers for Disease Control and Prevention, show that drug overdoses killed a record number of more than 70,000 Americans in 2017. To put this phenomenon into perspective, drug overdose deaths are higher than deaths from H.I.V., car crashes, or gun violence at their peaks.
We at AffirmHealth report often about the nationwide epidemic, but today we take a closer look at the state of New York. In 2015, New York prescribers wrote 10.2 million opioid prescriptions or 51.3 prescriptions per 100 patients–a 7.8 percent decline since 2013. This is also less than the national rate of 71 prescriptions per 100 patients (IMS Health).Read More
Opioids: A Global perspective. Treating Pain and Battling Addiction.Jan 2, 2019 2:34:09 PM by Jody Lutz
The Opioid Epidemic in America is a topic covered extensively, each and every day in the news. AffirmHealth covers this topically frequently as well, most recently in our, "Where are We Now?" article.Read More
Teens and Opioid AbuseDec 18, 2018 3:34:22 PM by Jody Lutz
Historically, research has shown that nearly 1 in 4 high school seniors in the United States have been exposed to prescription opioids through either medical or non-medical use. On November 12, 2018 a JAMA abstract reported: Between 1997 and 2012, the rate of hospitalization due to opioid poisonings nearly doubled in US children and adolescents. Opioid use early in life is associated with a higher likelihood of opioid misuse in the future. Read More
The Future of Managing Pain: Novel Treatments & ReformulationsNov 28, 2018 2:26:19 PM by Jody Lutz
As the opioid misuse and overdose epidemic impacts communities across America and has sweeping global implications, practitioners are looking to the future of pain management and the novel treatment options that may be on the horizon.Read More
MIPS and Improvement Activity DataNov 13, 2018 3:28:24 PM by Jody Lutz
Last week on the AffirmHealth Blog we discussed MIPS and PDMP Usage and promised a follow up on additional Improvement Activities. So this week we look at an Improvement Activities Data overview as well as a handful of activities potentially pertinent to providers prescribing opioids or other controlled substances.
Let’s start at the beginning…Read More
MIPS and PDMP Usage: How they work together.Oct 30, 2018 12:46:41 PM by Jody Lutz
MIPS: What is it and what do prescribers need to know?Read More
Naloxone and Buprenorphine...Access and Accessibility in AmericaOct 16, 2018 3:25:41 PM by Jody Lutz
Naloxone is a medication approved by the Food and Drug Administration (FDA) to prevent overdose by opioids it is designed to rapidly reverse opioid overdose. Commercially, it has been available for almost 50 years and several formulations are available, produced by various manufacturers.Read More
The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.